GlassScriptPhysician profile
Wendy E Thompson
NPI 1487049391
$2,746.44
in general payments reported to CMS, 2019-2025
19 companies · $875 in 2025
The $875 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $501 · 2022: $777 · 2023: $521 · 2024: $72.24 · 2025: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076 · Travel and Lodging: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,075.94 |
| Travel and Lodging | $392.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,165.45 | 2022-2025 | Inspire |
| Abbvie INC. | $485.84 | 2021-2025 | |
| Allergan, INC. | $251.45 | 2021-2022 | |
| Lilly USA, LLC | $142.70 | 2021-2023 | Emgality, Reyvow, Amyvid |
| Avadel Cns Pharmaceuticals, LLC | $141.89 | 2023 | Lumryz |
| Neurelis, INC. | $78.73 | 2022-2025 | Valtoco |
| Biohaven Pharmaceuticals, INC. | $77.42 | 2021 | |
| Emd Serono, INC. | $55.98 | 2021-2022 | |
| Lundbeck LLC | $54.27 | 2021-2022 | |
| Biogen, INC. | $50.27 | 2022 | |
| Sk Life Science, INC. | $46.36 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $43.02 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $37.73 | 2024 | |
| Pfizer INC. | $26.41 | 2023 | |
| Novartis Pharmaceuticals Corporation | $23.23 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.63 | 2022 | |
| Avanir Pharmaceuticals, INC. | $18.97 | 2021 | |
| Medtronic, INC. | $14.93 | 2022 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.